| Income Statement |
| Operating Expenses | 1.62M |
|
| Research and Development Expense | 893.00K |
| Selling, General and Administrative Expense | 730.00K |
| Operating Income | -1.62M |
| Net Income | -1.61M |
| Net Income Common Stock | -1.61M |
| Net Income Common Stock (USD) | -1.61M |
| Consolidated Income | -1.61M |
| Earnings per Basic Share | -0.13 |
| Earnings per Basic Share (USD) | -0.13 |
| Earnings per Diluted Share | -0.13 |
| Earning Before Interest & Taxes (EBIT) | -1.61M |
| Earning Before Interest & Taxes (USD) | -1.61M |
| Weighted Average Shares | 12.09M |
| Weighted Average Shares Diluted | 12.09M |
| Balance Sheet |
| Cash and Equivalents | 4.12M |
| Cash and Equivalents (USD) | 4.12M |
| Trade and Non-Trade Receivables | 30.00K |
| Current Assets | 4.30M |
| Property, Plant & Equipment Net | 286.00K |
| Total Assets | 4.76M |
| Debt Current | 293.00K |
| Total Debt | 293.00K |
| Current Liabilities | 2.06M |
| Total Liabilities | 2.06M |
| Accumulated Retained Earnings (Deficit) | -172.22M |
| Shareholders Equity | 2.70M |
| Shareholders Equity (USD) | 2.70M |
| Assets Non-Current | 457.00K |
| Total Debt (USD) | 293.00K |
| Trade and Non-Trade Payables | 541.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 124.00K |
| Net Cash Flow from Financing | 4.90M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.17M |
| Issuance (Purchase) of Equity Shares | 5.12M |
| Net Cash Flow from Operations | -1.73M |
| Share Based Compensation | 109.00K |